CAS: 23643-61-0 - (13alpha,16alpha,17alpha)-16-hydroxy-30-oxo-13,28-epoxyoleanan-3-yl beta-D-glucopyranosyl-(1->2)-[beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)]-alpha-L-arabinopyranoside
Formula:C52H84O22
InChI:InChI=1/C52H84O22/c1-46(2)27-7-11-49(5)28(8-12-52-29-15-47(3,21-55)13-14-51(29,22-68-52)30(57)16-50(49,52)6)48(27,4)10-9-31(46)72-44-40(74-43-39(65)36(62)33(59)24(17-53)69-43)35(61)26(20-67-44)71-45-41(37(63)34(60)25(18-54)70-45)73-42-38(64)32(58)23(56)19-66-42/h21,23-45,53-54,56-65H,7-20,22H2,1-6H3/t23-,24-,25-,26+,27+,28-,29-,30-,31?,32+,33-,34-,35+,36+,37+,38-,39-,40-,41-,42+,43+,44+,45+,47+,48+,49-,50+,51-,52+/m1/s1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ardisiacrispin A REF: 7W-GY3731CAS: 23643-61-0 | - - - | To inquire | Tue 10 Dec 24 |
 | Ardisiacrispin A REF: BP-BP0188CAS: 23643-61-0 | 95%~99% | 216.00 €~945.00 € | Thu 12 Dec 24 |
 | Ardisiacrispin A REF: TM-T3S2325CAS: 23643-61-0 | 99.43% | 89.00 €~1,075.00 € | Mon 16 Dec 24 |
 | Ardisiacrispin A REF: 3D-FA74358CAS: 23643-61-0 | Min. 95% | To inquire | Tue 21 Jan 25 |
Ref: 7W-GY3731
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: BP-BP0188
| 10mg | 216.00 € | ||
| 20mg | 365.00 € | ||
| 100mg | 945.00 € |
Estimated delivery in United States, on Thursday 12 Dec 2024
Ardisiacrispin A
CAS:23643-61-0
Ardisiacrispin A inhibits HepG2 cell growth, GI50=1.56μM; induces Bel-7402 cell apoptosis; A+B block HL-60 cell …
Formula:
C52H84O22
Purity:
99.43%
Color and Shape:
Solid
Molecular weight:
1061.21
Ref: TM-T3S2325
| 1mg | 89.00 € | ||
| 5mg | 183.00 € | ||
| 10mg | 270.00 € | ||
| 25mg | 539.00 € | ||
| 50mg | 769.00 € | ||
| 100mg | 1,075.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Ardisiacrispin A
CAS:23643-61-0
Ardisiacrispin A is a saponin that has been shown to be cytotoxic to cancer cells. …
Purity:
Min. 95%
Ref: 3D-FA74358
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
